Filing Details
- Accession Number:
- 0001209191-14-052079
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-13 14:28:06
- Reporting Period:
- 2014-08-11
- Filing Date:
- 2014-08-13
- Accepted Time:
- 2014-08-13 14:28:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891288 | Questcor Pharmaceuticals Inc | QCOR | Pharmaceutical Preparations (2834) | 330476164 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1509725 | H. Michael Mulroy | 1300 North Kellogg Drive, Suite D Anaheim CA 92807 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-08-06 | 1,349 | $0.00 | 75,714 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2014-08-11 | 5,000 | $92.35 | 70,714 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-08-11 | 5,000 | $92.32 | 65,714 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The prices reported in Column 4 are weighted average prices. These shares were sold in multiple transactions at prices ranging from $92.07 - $92.77. The Reporting Person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan (the "Automatic Trading Plan") adopted by the reporting person in the second quarter of 2013 and effective 90 days post-adoption. There have been no changes to the Automatic Trading Plan since its adoption. The first sale under the Automatic Trading Plan occurred on March 10, 2014, and there have been no sales by the Reporting Person outside of the Automatic Trading Plan since its adoption. The Automatic Trading Plan controls the exact dates and amounts of sales.
Billionaire Hedge Funds
